July 24, 2024 12:57 PM EDT

FDA finalizes guidance on using EHR data to support drug submissions

Zachary Brennan

Senior Editor

The FDA on Wednesday finalized guidance from 2021 that aims to help pharma companies understand when they may use data from electronic health records …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA finalizes guidance on using EHR data to support drug submissions

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Exclusive: Influential Democrat will oppose Biosecure Act ahead of House vote

Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston

Exclusive: Duke spinout launches in hopes of prevailing with brain cancer bispecific where Amgen, Roche did not

Novo Nordisk continues to grapple with patchy GLP-1 drug supply in Europe

BridgeBio sticks to script for ATTR-CM as Alnylam cleans up ‘typo’ snafu

How to secure full enrollment and a 30x ROI: A conversation with the CEO of the boutique enrollment agency doing just ...

FDA fi­nal­izes guid­ance on us­ing EHR da­ta to sup­port drug sub­mis­sions

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

FDA finalizes guidance on using EHR data to support drug submissions